Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Anelixis Therapeutics

Request full access

Advancing neurodegenerative and autoimmune treatments through targeted biologic therapies

Cambridge, United StatesFounded 2012Biotech & Life Sciences

About Anelixis Therapeutics

Anelixis Therapeutics is a biotechnology company focused on developing innovative therapies that target immune system modulation to treat chronic diseases. The company operates in the biopharmaceutical market, primarily serving patients with autoimmune and neurodegenerative conditions. Anelixis Therapeutics employs a research-driven business model, leveraging cutting-edge science to discover and develop novel treatments. Revenue is generated through partnerships, licensing agreements, and potential future product sales. The company aims to address unmet medical needs by advancing its pipeline of therapeutic candidates through clinical trials and regulatory approvals.

Source: Dealroom company data

Anelixis Therapeutics in the Cambridge ecosystem

Live from Dealroom

The Anelixis Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • BVF Partners
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Cambridge HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Anelixis Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Anelixis Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.